
PMC:2889865 / 12925-13134
Annnotations
pmc-enju-pas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5306 | 0-4 | NN | denotes | Ca2+ |
T5307 | 5-8 | VB | denotes | was |
T5308 | 9-17 | VB | denotes | observed |
T5309 | 18-20 | TO | denotes | to |
T5310 | 21-29 | VB | denotes | increase |
T5311 | 30-34 | NN | denotes | AP-1 |
T5312 | 35-43 | NN | denotes | activity |
T5313 | 44-45 | -LRB- | denotes | ( |
T5314 | 45-51 | NN | denotes | figure |
T5315 | 52-54 | NN | denotes | 1c |
T5316 | 54-55 | -RRB- | denotes | ) |
T5317 | 56-59 | CC | denotes | and |
T5318 | 60-66 | VB | denotes | reduce |
T5319 | 67-72 | NN | denotes | NF-κB |
T5320 | 73-81 | NN | denotes | activity |
T5321 | 82-83 | -LRB- | denotes | ( |
T5322 | 83-89 | NN | denotes | figure |
T5323 | 90-92 | NN | denotes | 2e |
T5324 | 92-93 | -RRB- | denotes | ) |
T5325 | 93-94 | -COLON- | denotes | ; |
T5326 | 95-104 | RB | denotes | therefore |
T5327 | 104-105 | -COMMA- | denotes | , |
T5328 | 106-108 | PRP | denotes | we |
T5329 | 109-116 | VB | denotes | exposed |
T5330 | 117-124 | NN | denotes | T-cells |
T5331 | 125-127 | TO | denotes | to |
T5332 | 128-129 | DT | denotes | a |
T5333 | 130-133 | NN | denotes | PKC |
T5334 | 134-143 | NN | denotes | inhibitor |
T5335 | 144-152 | RB | denotes | together |
T5336 | 153-157 | IN | denotes | with |
T5337 | 158-161 | NN | denotes | PMA |
T5338 | 162-164 | TO | denotes | to |
T5339 | 165-174 | VB | denotes | determine |
T5340 | 175-178 | PRP-DOLLAR- | denotes | its |
T5341 | 179-185 | NN | denotes | effect |
T5342 | 186-188 | IN | denotes | on |
T5343 | 189-197 | NN | denotes | cytokine |
T5344 | 198-208 | NN | denotes | expression |
R4354 | T5306 | T5307 | arg1Of | Ca2+,was |
R4355 | T5306 | T5308 | arg2Of | Ca2+,observed |
R4356 | T5306 | T5310 | arg1Of | Ca2+,increase |
R4357 | T5306 | T5318 | arg1Of | Ca2+,reduce |
R4358 | T5308 | T5307 | arg2Of | observed,was |
R4359 | T5308 | T5325 | arg1Of | observed,; |
R4360 | T5310 | T5317 | arg1Of | increase,and |
R4361 | T5312 | T5310 | arg2Of | activity,increase |
R4362 | T5312 | T5311 | arg1Of | activity,AP-1 |
R4363 | T5312 | T5313 | arg1Of | activity,( |
R4364 | T5315 | T5313 | arg2Of | 1c,( |
R4365 | T5315 | T5314 | arg1Of | 1c,figure |
R4366 | T5316 | T5313 | arg3Of | ),( |
R4367 | T5317 | T5308 | arg3Of | and,observed |
R4368 | T5317 | T5309 | arg1Of | and,to |
R4369 | T5318 | T5317 | arg2Of | reduce,and |
R4370 | T5320 | T5318 | arg2Of | activity,reduce |
R4371 | T5320 | T5319 | arg1Of | activity,NF-κB |
R4372 | T5320 | T5321 | arg1Of | activity,( |
R4373 | T5323 | T5321 | arg2Of | 2e,( |
R4374 | T5323 | T5322 | arg1Of | 2e,figure |
R4375 | T5324 | T5321 | arg3Of | ),( |
R4376 | T5328 | T5329 | arg1Of | we,exposed |
R4377 | T5328 | T5339 | arg1Of | we,determine |
R4378 | T5329 | T5325 | arg2Of | exposed,; |
R4379 | T5329 | T5326 | arg1Of | exposed,therefore |
R4380 | T5329 | T5327 | arg1Of | exposed,"," |
R4381 | T5329 | T5331 | arg1Of | exposed,to |
R4382 | T5329 | T5335 | arg1Of | exposed,together |
R4383 | T5329 | T5338 | modOf | exposed,to |
R4384 | T5330 | T5329 | arg2Of | T-cells,exposed |
R4385 | T5334 | T5331 | arg2Of | inhibitor,to |
R4386 | T5334 | T5332 | arg1Of | inhibitor,a |
R4387 | T5334 | T5333 | arg1Of | inhibitor,PKC |
R4388 | T5335 | T5336 | arg1Of | together,with |
R4389 | T5337 | T5336 | arg2Of | PMA,with |
R4390 | T5339 | T5338 | arg1Of | determine,to |
R4391 | T5341 | T5339 | arg2Of | effect,determine |
R4392 | T5341 | T5340 | arg1Of | effect,its |
R4393 | T5341 | T5342 | arg1Of | effect,on |
R4394 | T5344 | T5342 | arg2Of | expression,on |
R4395 | T5344 | T5343 | arg1Of | expression,cytokine |
bionlp-st-ge-2016-spacy-parsed
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4933 | 0-3 | CD | denotes | Ca2 |
T4934 | 3-4 | NN | denotes | + |
T4935 | 5-8 | VBD | denotes | was |
T4936 | 9-17 | VBN | denotes | observed |
T4937 | 18-20 | TO | denotes | to |
T4938 | 21-29 | VB | denotes | increase |
T4939 | 30-34 | JJ | denotes | AP-1 |
T4940 | 35-43 | NN | denotes | activity |
T4941 | 44-45 | -LRB- | denotes | ( |
T4942 | 45-51 | NN | denotes | figure |
T4943 | 52-54 | CD | denotes | 1c |
T4944 | 54-55 | -RRB- | denotes | ) |
T4945 | 56-59 | CC | denotes | and |
T4946 | 60-66 | VB | denotes | reduce |
T4947 | 67-72 | JJ | denotes | NF-κB |
T4948 | 73-81 | NN | denotes | activity |
T4949 | 82-83 | -LRB- | denotes | ( |
T4950 | 83-89 | NN | denotes | figure |
T4951 | 90-92 | CD | denotes | 2e |
T4952 | 92-93 | -RRB- | denotes | ) |
T4953 | 93-94 | : | denotes | ; |
T4954 | 95-104 | RB | denotes | therefore |
T4955 | 104-105 | , | denotes | , |
T4956 | 106-108 | PRP | denotes | we |
T4957 | 109-116 | VBD | denotes | exposed |
T4958 | 117-124 | NNS | denotes | T-cells |
T4959 | 125-127 | TO | denotes | to |
T4960 | 128-129 | DT | denotes | a |
T4961 | 130-133 | NNP | denotes | PKC |
T4962 | 134-143 | NN | denotes | inhibitor |
T4963 | 144-152 | RB | denotes | together |
T4964 | 153-157 | IN | denotes | with |
T4965 | 158-161 | NNP | denotes | PMA |
T4966 | 162-164 | TO | denotes | to |
T4967 | 165-174 | VB | denotes | determine |
T4968 | 175-178 | PRP$ | denotes | its |
T4969 | 179-185 | NN | denotes | effect |
T4970 | 186-188 | IN | denotes | on |
T4971 | 189-197 | NN | denotes | cytokine |
T4972 | 198-208 | NN | denotes | expression |
T4973 | 208-209 | . | denotes | . |
R3982 | T4933 | T4934 | nummod | Ca2,+ |
R3983 | T4934 | T4936 | nsubjpass | +,observed |
R3984 | T4935 | T4936 | auxpass | was,observed |
R3985 | T4936 | T4957 | ccomp | observed,exposed |
R3986 | T4937 | T4938 | aux | to,increase |
R3987 | T4938 | T4936 | xcomp | increase,observed |
R3988 | T4939 | T4940 | amod | AP-1,activity |
R3989 | T4940 | T4938 | dobj | activity,increase |
R3990 | T4941 | T4942 | punct | (,figure |
R3991 | T4942 | T4938 | parataxis | figure,increase |
R3992 | T4943 | T4942 | nummod | 1c,figure |
R3993 | T4944 | T4942 | punct | ),figure |
R3994 | T4945 | T4938 | cc | and,increase |
R3995 | T4946 | T4938 | conj | reduce,increase |
R3996 | T4947 | T4948 | amod | NF-κB,activity |
R3997 | T4948 | T4946 | dobj | activity,reduce |
R3998 | T4949 | T4950 | punct | (,figure |
R3999 | T4950 | T4957 | ccomp | figure,exposed |
R4000 | T4951 | T4950 | nummod | 2e,figure |
R4001 | T4952 | T4950 | punct | ),figure |
R4002 | T4953 | T4957 | punct | ;,exposed |
R4003 | T4954 | T4957 | advmod | therefore,exposed |
R4004 | T4955 | T4957 | punct | ",",exposed |
R4005 | T4956 | T4957 | nsubj | we,exposed |
R4006 | T4957 | T4957 | ROOT | exposed,exposed |
R4007 | T4958 | T4957 | dobj | T-cells,exposed |
R4008 | T4959 | T4957 | prep | to,exposed |
R4009 | T4960 | T4962 | det | a,inhibitor |
R4010 | T4961 | T4962 | compound | PKC,inhibitor |
R4011 | T4962 | T4959 | pobj | inhibitor,to |
R4012 | T4963 | T4964 | advmod | together,with |
R4013 | T4964 | T4957 | prep | with,exposed |
R4014 | T4965 | T4964 | pobj | PMA,with |
R4015 | T4966 | T4967 | aux | to,determine |
R4016 | T4967 | T4957 | advcl | determine,exposed |
R4017 | T4968 | T4969 | poss | its,effect |
R4018 | T4969 | T4967 | dobj | effect,determine |
R4019 | T4970 | T4969 | prep | on,effect |
R4020 | T4971 | T4972 | amod | cytokine,expression |
R4021 | T4972 | T4970 | pobj | expression,on |
R4022 | T4973 | T4957 | punct | .,exposed |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5558 | 130-133 | http://purl.obolibrary.org/obo/GO_0004697 | denotes | PKC |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5577 | 130-133 | http://purl.obolibrary.org/obo/GO_0004697 | denotes | PKC |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5587 | 119-124 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4759 | 0-209 | Sentence | denotes | Ca2+ was observed to increase AP-1 activity (figure 1c) and reduce NF-κB activity (figure 2e); therefore, we exposed T-cells to a PKC inhibitor together with PMA to determine its effect on cytokine expression. |
T95 | 0-209 | Sentence | denotes | Ca2+ was observed to increase AP-1 activity (figure 1c) and reduce NF-κB activity (figure 2e); therefore, we exposed T-cells to a PKC inhibitor together with PMA to determine its effect on cytokine expression. |
bionlp-st-ge-2016-reference-tees
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5898 | 30-34 | Protein | denotes | AP-1 |
T5899 | 67-72 | Protein | denotes | NF-κB |
T5900 | 130-133 | Protein | denotes | PKC |
T5901 | 21-29 | Positive_regulation | denotes | increase |
T5902 | 60-66 | Negative_regulation | denotes | reduce |
T5903 | 134-143 | Negative_regulation | denotes | inhibitor |
R4767 | T5898 | T5901 | themeOf | AP-1,increase |
R4768 | T5899 | T5902 | themeOf | NF-κB,reduce |
R4769 | T5900 | T5903 | themeOf | PKC,inhibitor |
bionlp-st-ge-2016-uniprot
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5520 | 30-34 | P05412 | denotes | AP-1 |